Management and characteristics of patients suffering from Clostridiodes difficile infection in primary care

References

• Furuya-Kanamori L, Stone JC, Clark J, et al. Comorbidities, exposure to medications, and the risk of community-acquired clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015;36(2):132–141.
   PubMed Web of Science ®Google Scholar
• Ananthakrishnan AN, Oxford EC, Nguyen DD, et al. Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol Ther. 2013;38(5):522–530.
   PubMed Web of Science ®Google Scholar
• Turner NA, Grambow SC, Woods CW, et al. Epidemiologic trends in Clostridioides difficile infections in a regional community hospital network. JAMA Netw Open. 2019;2(10):e1914149.
   PubMed Web of Science ®Google Scholar
• Khanna S, Pardi DS, Aronson SL, et al. The epidemiology of community-acquired Clostridium difficile infection: a population-based study. Am J Gastroenterol. 2012;107(1):89–95.
   PubMed Web of Science ®Google Scholar
• Czepiel J, Dróżdż M, Pituch H, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38(7):1211–1221.
   PubMed Web of Science ®Google Scholar
• Barbut F, Ramé L, Petit A, et al. [Prevalence of Clostridium difficile infection in hospitalized patients with diarrhea: results of a French prospective multicenter bi-annual point prevalence study]. Presse Medicale Paris Fr 1983. 2015;44(4Pt1):e75–83.
   Google Scholar
• Carmeliet T, Zachée P, Dits H, et al. Acute primary abdominal compartment syndrome due to Clostridium difficile induced toxic megacolon: a case report and review of the literature. Anaesthesiol Intensive Ther. 2019;51(4):273–282.
   PubMed Web of Science ®Google Scholar
• Lee HS, Plechot K, Gohil S, et al. Clostridium difficile: Diagnosis and the consequence of over diagnosis. Infect Dis Ther. 2021;10(2):687–697.
   PubMed Web of Science ®Google Scholar
• Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364(5):422–431.
   PubMed Web of Science ®Google Scholar
• Polivkova S, Krutova M, Capek V, et al. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection — an observational cohort study. Int J Infect Dis. 2021;103:226–233.
   PubMed Web of Science ®Google Scholar
• Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83(3):457–502.
   PubMed Web of Science ®Google Scholar
• McNulty CA, Lasseter G, Verlander NQ, et al. Management of suspected infectious diarrhoea by english GPs: are they right? Br J Gen Pract. 2014;64(618):e24–30–e30.
   PubMed Web of Science ®Google Scholar
• Karlström O, Fryklund B, Tullus K, et al. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden. The Swedish C. difficile study group. Clin Infect Dis. 1998;26(1):141–145.
   PubMed Web of Science ®Google Scholar
• Bauer MP, Veenendaal D, Verhoef L, et al. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2009;15(12):1087–1092.
   PubMed Web of Science ®Google Scholar
• Lessa FC, Mu Y, Bamberg WM, et al. Burden of Clostridium difficile infection in the United States. N Engl J Med. 2015;372(9):825–834.
   PubMed Web of Science ®Google Scholar
• Gupta A, Khanna S. Community-acquired Clostridium difficile infection: an increasing public health threat. Infect Drug Resist. 2014;7:63–72.
   PubMed Web of Science ®Google Scholar
• Pardi DS, Khanna S. In search of the (Clostridium difficile) Holy Grail. Clin Infect Dis off Publ Infect Dis Soc Am. 2020;70(6):1094–1095.
   PubMed Web of Science ®Google Scholar
• Barbut F, Richard A, Hamadi K, et al. Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea. J Clin Microbiol. 2000;38(6):2386–2388.
   PubMed Web of Science ®Google Scholar
• McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of america (IDSA) and society for healthcare epidemiology of america (SHEA). Clin Infect Dis. 2018;66(7):e1–48.
   Web of Science ®Google Scholar
• Hensgens MPM, Dekkers OM, Demeulemeester A, et al. Diarrhoea in general practice: when should a Clostridium difficile infection be considered? Results of a nested case-control study. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2014;20(12):O1067–1074.
   PubMed Web of Science ®Google Scholar
• Starfield B, Lemke KW, Herbert R, et al. Comorbidity and the use of primary care and specialist care in the elderly. Ann Fam Med. 2005;3(3):215–222.
   PubMed Web of Science ®Google Scholar
• Lefevre-Tantet-Etchebarne D, Sivadon-Tardy V, Davido B, et al. Community-acquired Clostridium difficile infections in emergency departments. Med Mal Infect. 2016;46(7):372–379.
   PubMed Web of Science ®Google Scholar
• Shen EP, Surawicz CM. Current treatment options for severe Clostridium difficile–associated disease. Gastroenterol Hepatol. 2008;4(2):134–139.
   Google Scholar
• Johnson S, Homann SR, Bettin KM, et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med. 1992;117(4):297–302.
   PubMed Web of Science ®Google Scholar
• Koo HL, Koo DC, Musher DM, et al. Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis. Clin Infect Dis. 2009;48(5):598–605.
   PubMed Web of Science ®Google Scholar
• Ross CL, Spinler JK, Savidge TC. Structural and functional changes within the gut microbiota and susceptibility to Clostridium difficile infection. Anaerobe. 2016;41:37–43.
   PubMed Web of Science ®Google Scholar